NAPROSYN
ATNAHS PHARMA UK LIMITED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of NAPROSYN in Canada?
Yes. NAPROSYN 500MG has an active shortage reported to Health Canada (last updated July 27, 2026).
When will NAPROSYN be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
NAPROSYN E TAB 500MG
SYNTEX INC.
Other Products
NAPROSYN SUP 500MG
SYNTEX INC.
RATIO-NAPROXEN
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
NAPROSYN 375MG
SYNTEX INC.
SYNFLEX TAB 275MG
ALTIMED PHARMA INC.
ANAPROX
SYNTEX INC.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02162423
Strength
500MG
Dosage Form
TABLET (ENTERIC-COATED)
Route
ORAL
Active Ingredient
NAPROXEN
Tier
Unrated
Last Updated
2026-07-27
Reason for Shortage
Other (Please describe in comments)
Past Reports for This Drug
NAPROSYN has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from ATNAHS PHARMA UK LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.